Comparison between FCML Distributors IPO and Invicta Diagnostic IPO.
FCML Distributors IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Invicta Diagnostic IPO is a SME Bookbuilding proposed to list at NSE SME.
The total issue size of FCML Distributors IPO is up to ₹0.00 Cr whereas the issue size of the Invicta Diagnostic IPO is up to ₹26.71 Cr. The final issue price of FCML Distributors IPO is and of Invicta Diagnostic IPO is ₹85.00 per share.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹80.00 per share | |
| Issue Price (Upper) | ₹85.00 per share | |
| Issue Price (Final) | ₹85.00 per share | |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 1600 shares | |
| Fresh Issue Size | 45,96,000 shares | 31,42,400 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹26.71 Cr |
| OFS Issue Size | 11,46,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 57,42,000 shares | 31,42,400 shares |
| Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹26.71 Cr |
FCML Distributors IPO opens on , while Invicta Diagnostic IPO opens on Dec 01, 2025. The closing date of FCML Distributors IPO and Invicta Diagnostic IPO is , and Dec 03, 2025, respectively.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Bid Date | Nov 28, 2025 | |
| Issue Open | Dec 01, 2025 | |
| Issue Close | Dec 03, 2025 | |
| Basis Of Allotment (Tentative) | Dec 04, 2025 | |
| Initiation of Refunds (Tentative) | Dec 05, 2025 | |
| Credit of Share (Tentative) | Dec 05, 2025 | |
| Listing date (Tentative) | Dec 08, 2025 | |
| Anchor Lockin End date 1 | Jan 02, 2026 | |
| Anchor Lockin End date 2 | Mar 03, 2026 |
FCML Distributors IPO P/E ratio is , as compared to Invicta Diagnostic IPO P/E ratio of 14.51.
| FCML Distributors IPO | Invicta Diagnostic IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)FCML Distributors Ltd.'s revenue increased by 14% and profit after tax (PAT) rose by 17% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Invicta Diagnostic Ltd.'s revenue increased by 90% and profit after tax (PAT) rose by 30% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100 | 90.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.69 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 14.51 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹106.86 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 34.29% | 44.28% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 37.93% | 42.00% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.26 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹5.86 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 29.27% | 36.25% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the FCML Distributors IPO Retail Individual Investors (RII) are offered 0 shares while in Invicta Diagnostic IPO retail investors are offered 0 shares. Qualified Institutional Buyers (QIB) are offered 0 shares in FCML Distributors IPO and 5,34,400 shares in Invicta Diagnostic IPO.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 7,98,400 shares |
| Market Maker Reservation | 0 shares | 1,66,400 shares |
| QIB | 0 shares | 5,34,400 shares |
| NII | 0 shares | 5,42,400 shares |
| RII | 0 shares | 12,67,200 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 0 shares | 31,42,400 shares |
FCML Distributors IPO subscribed in total, whereas Invicta Diagnostic IPO subscribed 4.27x.
| FCML Distributors IPO | Invicta Diagnostic IPO | |
|---|---|---|
| QIB (times) | 3.51x | |
| NII (times) | 6.96x | |
| Big NII (times) | 7.30x | |
| Small NII (times) | 6.27x | |
| RII (times) | 3.44x | |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 4.27x |
